Sarah Johnson
Metabolomics, a comprehensive analysis of small molecules in biological systems, has emerged as a powerful tool in precision medicine for cancer. Mass spectrometry-based metabolomics has witnessed significant advancements in recent years, enabling the identification and quantification of metabolites with high sensitivity and accuracy. This review highlights the recent developments in mass spectrometry-based metabolomics and its applications in precision medicine for cancer. We discuss the analytical techniques, data processing methods, and statistical approaches utilized in metabolomics studies. Furthermore, we explore the role of metabolomics in cancer diagnosis, prognosis, treatment response prediction, and identification of novel therapeutic targets. We also address the challenges and future perspectives of mass spectrometry-based metabolomics in cancer research. Overall, the integration of metabolomics into precision medicine has the potential to revolutionize cancer management and improve patient outcomes.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 